Applications of 2,3-O-Isopropylidene-D-Erythronolactone in Industrial Manufacturing

2,3-O-Isopropylidene-D-Erythronolactone is a chiral intermediate widely applied in the synthesis of complex molecules across multiple industrial fields. As a raw material manufacturer, we supply this lactone to downstream producers with strict requirements for purity, traceability, and process integration. Its role in advanced organic synthesis, especially where stereochemistry and functional group protection is critical, supports key manufacturing sectors listed below.

1. Pharmaceutical API Synthesis

Our material serves as a protected building block in the production of nucleoside analogues and other chiral active pharmaceutical ingredients (APIs). Multinational API manufacturers incorporate this lactone at defined steps in stereoselective routes, especially for cardiovascular and antiviral drug compounds. Chemical engineers employ this lactone for its high yield and defined reactivity, reducing risk of racemization during downstream transformations.

Industry compliance standards

• ICH Q7 GMP for Active Pharmaceutical Ingredients
• USP/NF specifications for raw materials
• EDQM CEP requirements for pharmaceutical starting materials
• FDA 21 CFR Part 210/211

Typical usage ratio

• Ranges from 0.8 to 1.1 molar equivalents in protected sugar backbone synthesis
• Adjusted depending on downstream coupling yields and impurity profile controls
• Batch scale production: 100–500 kg per campaign
• Pilot scale: 5–40 kg per lot

Downstream process integration

• Introduced in the early steps of nucleoside synthesis as a chiral synthon
• Typically follows selective hydrolysis and activation steps
• Serves as a precursor for further phosphorylation or glycosylation stages
• Removed after main chain construction to reveal free hydroxyls for API finishing

Final product types

• Nucleoside analog active APIs (e.g., anti-HIV, anti-influenza drugs)
• Platelet aggregation inhibitors
• Intermediate fragments for peptide nucleic acids
• Custom chiral intermediates for licensed production

2. Specialty Chemical Synthesis for Fine Flavors and Fragrances

Leading producers in the fine chemicals sector use our lactone for the stereoselective assembly of protected polyols and rare sugar-derived aroma molecules. Its isopropylidene protection offers stability during multistep reactions, especially for manufacturing complex esters and lactones used as high-value flavor and fragrance components. Precise control over configuration is critical to meet sensory and regulatory requirements.

Industry compliance standards

• IFRA Standards for fragrance material purity and safety
• EU Regulation (EC) No 1334/2008 (Flavourings and certain food ingredients)
• REACH Registration for raw material traceability
• ISO 9001:2015 Quality Management for ingredient suppliers

Typical usage ratio

• 0.5 to 1.5 equivalents per target molecule in multi-component syntheses
• Blending ratios adjusted for retention of chiral integrity during deprotection
• Batch process consumption: 10–30 kg per batch
• Pilot studies: 1–5 kg test lots

Downstream process integration

• Protection of polyhydroxy intermediates in sequential transformations
• Identification and monitoring via HPLC/GC-MS at each synthetic stage
• Deprotection by mild acid hydrolysis post core synthesis
• Final purification for incorporation into liquid or solid blends

Final product types

• Niche aroma chemicals (e.g., lactonic bases, rare sugar esters)
• Natural-identical flavor bases for beverages and confectionery
• Fragrance ingredients for perfumery bases
• Specialty odorants for home and personal care blends

3. Advanced Polymer and Biopolymer Monomer Synthesis

Producers of high-performance polymers and biodegradable plastics adopt this chemical for the synthesis of functionalized monomers with defined stereochemistry. The isopropylidene group enables selective deprotection and modification during monomer design, supporting the demand for ultra-pure input materials in smart and medical-grade polymers. Strict in-house analytics monitor impurity carryover during scale-up.

Industry compliance standards

• ISO 9001 and ISO 14001 certified process controls
• EU Directive 2011/65/EU (RoHS)
• FDA 21 CFR 177 for polymers in food contact
• USP Class VI plastics for medical applications

Typical usage ratio

• 5%–12% (w/w) as comonomer feed for block or random copolymer synthesis
• Stoichiometry adjusted to modulate ester, carbonate, or amide ratios in copolymers
• Production scale: 50–250 kg per continuous run
• Developmental scale: 2–10 kg for custom batches

Downstream process integration

• Introduced in solution polymerization via ring-opening reactions
• Feeds into reactive extrusion during melt processing
• Removal of protecting group before or after polymer chain growth as required
• In-process QC by GPC and NMR for chain structure validation

Final product types

• Medical-grade polycarbonates and polyesters
• Biodegradable copolymers for packaging
• Functional polymer coatings for electronics and diagnostics
• Hydrophilic bio-based plastics

4. Carbohydrate-Based Research Reagents

Leading biotech and life science reagent firms employ our lactone as a precursor to protected sugars and rare carbohydrate derivatives. Controlled use supports production of analytical standards, diagnostic reagents, and oligosaccharide synthesis kits. The need for batch reproducibility, high purity, and robust documentation is critical for traceability in regulated research supply chains.

Industry compliance standards

• ISO 13485 for medical device component manufacturing
• European Pharmacopoeia (Ph. Eur.) monographs on raw materials
• US Pharmacopeia (USP) for reagent quality
• GLP supplier documentation and batch traceability

Typical usage ratio

• 0.2–1.0 molar equivalent depending on desired carbohydrate structure
• Exact ratio tuned for maximal recovery during multi-step synthesis
• Pilot production: 1–20 kg per campaign
• Small unit packaging for researcher supply: 25–500 g

Downstream process integration

• Employed as a precursor for protected glycoside library synthesis
• Introduced before coupling or deprotection in solid-phase assembly
• Removal of isopropylidene under acidic conditions monitored by HPLC
• Packaged in inert conditions for researcher and diagnostic kit supply

Final product types

• Rare monosaccharide standards
• Glycan arrays and oligosaccharide synthesis kits
• Enzyme substrates for research
• Labeled carbohydrates for lab studies